Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)

N/ACompletedNCT00652067

Yale University1 enrolled

Overview

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Infection, Mycobacterium Avium-Intracellulare

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Treatment of one patient with MAI Exclusion Criteria: * No other patients will be treated

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.